Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.8 SEK | +1.72% | +4.12% | +14.56% |
04-25 | Transcript : Bactiguard Holding AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
04-25 | Bactiguard Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+14.56% | 223M | C- | ||
+9.64% | 27.84B | B+ | ||
-29.83% | 3.04B | B- | ||
-15.97% | 2.56B | C+ | ||
+18.11% | 2.33B | - | A- | |
+3.70% | 1.99B | B | ||
-9.47% | 1.87B | - | ||
-2.22% | 1.49B | B | ||
+2.19% | 1.27B | - | ||
+18.92% | 1.15B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BACTI B Stock
- Ratings Bactiguard Holding AB